- Product Details
Keywords
- Partial PROTAC
- Pomalidomide-2-2-2-2-2-2-6-N3, 24-azido-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-3,6,9,12,15,18-hexaoxatetracosanamide
- Template for synthesis of targeted protein degrader
Quick Details
- ProName: Pomalidomide-PEG6-butyl azide
- Molecular Formula: C31H44N6O11
- Application: Partial PROTAC Pomalidomide-PEG6-butyl...
- PackAge: 50MG
- Purity: >=95%
- LimitNum: 0
Superiority
Partial PROTAC Pomalidomide-PEG6-butyl azide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a linker with both hydrophobic and hydrophilic moieties, and a pendant azide for click chemistry with a target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other Partial PROTACs with a pendant azide group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.